Lockheed Martin Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.83M | Buy |
10,860
+2,760
| +34% | +$1.23M | 0.18% | 79 |
|
|
2025
Q1 | $3.93M | Sell |
8,100
-190
| -2% | -$92.1K | 0.16% | 81 |
|
|
2024
Q4 | $3.34M | Sell |
8,290
-1,660
| -17% | -$668K | 0.13% | 85 |
|
|
2024
Q3 | $4.63M | Buy |
+9,950
| New | +$4.63M | 0.21% | 70 |
|
|
2021
Q1 | – | Sell |
-24,320
| Closed | -$5.75M | – | 90 |
|
|
2020
Q4 | $5.75M | Buy |
24,320
+8,500
| +54% | +$2.01M | 0.3% | 63 |
|
|
2020
Q3 | $4.3M | Buy |
+15,820
| New | +$4.3M | 0.27% | 56 |
|
|
2019
Q3 | – | Sell |
-33,950
| Closed | -$6.23M | – | 94 |
|
|
2019
Q2 | $6.23M | Buy |
33,950
+18,950
| +126% | +$3.47M | 0.28% | 82 |
|
|
2019
Q1 | $2.76M | Buy |
+15,000
| New | +$2.76M | 0.13% | 81 |
|
|
2018
Q3 | – | Sell |
-4,100
| Closed | -$697K | – | 84 |
|
|
2018
Q2 | $697K | Sell |
4,100
-1,200
| -23% | -$204K | 0.03% | 72 |
|
|
2018
Q1 | $864K | Buy |
+5,300
| New | +$864K | 0.04% | 96 |
|
|
2015
Q3 | – | Sell |
-9,500
| Closed | -$1.17M | – | 132 |
|
|
2015
Q2 | $1.17M | Sell |
9,500
-26,800
| -74% | -$3.31M | 0.06% | 88 |
|
|
2015
Q1 | $4.28M | Buy |
+36,300
| New | +$4.28M | 0.21% | 50 |
|